Surveillance of Pancreatic Health After Diabetes Diagnosis

Who May Qualify: - 50 - 84 years of age at the time of enrolment (within year of birth, not month of birth) - Haemoglobin A1c (HbA1c) ≥ 48 or 6.5% and/or confirmed type II DM diagnosed within the last 180 days (+20 days flexibility allowance) - Willing to provide up to 30 mL of blood for each study visit - Willing and eligible to undergo MRI scan (or CT scan if MRI is contraindicated) - Understands the study process and is willing to take part in the study and sign the willing to sign a consent form form Who Should NOT Join This Trial: - Prior type I or type II DM diagnosis \> 6 months - A history of pancreatic cancer, pancreatic neuroendocrine tumour (pNET) or Pancreatitis - Under investigation for pancreatic cancer / pancreatic cyst - Any known pancreatic surgery (not including ERCP), or other major surgery requiring anaesthesia within 3 months - Any invasive solid or haematological cancer in the past 3 years, including cancer recurrence after treatment in the last 3 years - Current chronic or acute oral or systemic steroid use within 3 months of initial HbA1c or diabetes diagnosis (estimate rather than accurate) - Blood transfusion within 1 month - Solid organ transplant recipient - Currently pregnant - Needing dialysis Always talk to your doctor about whether this trial is right for you.